Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01954160 · ClinicalTrials.gov registry record · Phase 2
Study of Renal Denervation in Patients With Heart Failure
A Phase 2 study, sponsored by Adrian Hernandez.
- Terminated
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT01954160 is a Phase 2 study that was terminated before completion, run by Adrian Hernandez. The registered enrollment target is 5 participants.
The verdict
NCT01954160, a Phase 2 study, was terminated before completion, sponsored by Adrian Hernandez.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
Congestive heart failure is a common disorder in which the heart cannot pump enough blood to meet the needs of the rest of the body. Poor sodium handling by the kidneys is a damaging effect of heart failure, and it leads to symptoms of congestion such as shortness of breath or ankle swelling. Recent studies suggest that reducing the nerve activity to a kidney could reduce sodium retention and blood pressure. An improvement in the way the kidneys handle sodium may reduce disease progression and decrease symptoms for heart failure patients.
Interventions
- DEVICE Symplicity Renal Denervation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01954160
The ClinicalTrials.gov registry entry for NCT01954160 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Adrian Hernandez, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Symplicity Renal Denervation is the first listed.
NCT01954160 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01954160 about?
NCT01954160 is a clinical study titled "Study of Renal Denervation in Patients With Heart Failure". Congestive heart failure is a common disorder in which the heart cannot pump enough blood to meet the needs of the rest of the body. Poor sodium handling by the kidneys is a damaging effect of heart failure, and it leads to symptoms of congestion such as shortness of breath or ankle swelling. Recent...
What is the current status of trial NCT01954160?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2013-12. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01954160?
The interventions under investigation include: Symplicity Renal Denervation (DEVICE).
Who is sponsoring clinical trial NCT01954160?
This trial is sponsored by Adrian Hernandez, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.